|
"Generic Erbitux for Treatment of EGFR+ Cancer."
|
N44CO120044-000
|
$2,479,561
|
$1,239,781
|
HU, PEISHENG
|
CANCER THERAPEUTICS LABORATORY INC
|
|
15-LOX-1 effects on colitis and colon cancer
|
5R01CA137213-04
|
$309,964
|
$309,964
|
SHUREIQI, IMAD
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
2-Amino-9H-pyrido[2,3-b]indole: a potential colorectal carcinogen formed in tobac
|
5R01CA134700-03
|
$327,269
|
$327,269
|
Turesky, Robert
|
WADSWORTH CENTER
|
|
A 3-D in vitro platform of tumor metastasis (PQ24)
|
1R01CA170879-01
|
$338,175
|
$338,175
|
GEORGE, STEVEN
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
A Cellular and Molecular Analysis of the Intravasation Step in Tumor Metastasis
|
5R01CA129484-05
|
$381,417
|
$95,354
|
QUIGLEY, JAMES
|
SCRIPPS RESEARCH INSTITUTE
|
|
A Center for the Convergence of Physical Science and Cancer Biology
|
5U54CA143862-04
|
$1,680,677
|
$840,339
|
Davies, Paul
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
1UM1CA164974-01A1
|
$2,196,670
|
$439,334
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Follow-up Study for Causes of Illness in Black Women
|
5R01CA058420-19
|
$1,716,455
|
$858,228
|
Rosenberg, Lynn
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Genetic Model for Early-Onset Breast and Colon Cancer in African Americans
|
1U01CA158428-01A1
|
$342,475
|
$171,238
|
Buckhaults, Phillip
|
GEORGIA HEALTH SCIENCES UNIVERSITY
|
|
A Multi-State Study of Cancer Treatment and Outcomes Among American Indians
|
5R01CA125231-06
|
$374,097
|
$59,856
|
RAMSEY, SCOTT
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
A novel agent suppresses colitis and colon cancer
|
1R03CA158669-01A1
|
$78,500
|
$78,500
|
Ouyang, Nengtai
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
A Prospective Study of Colorectal Cancer: One-Carbon Metabolism and Inflammation
|
5R01CA120523-05
|
$488,576
|
$488,576
|
ULRICH, CORNELIA
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
A Risk Prediction Model for Colorectal Cancer Screening
|
5R01CA131197-05
|
$430,622
|
$430,622
|
SCHROY, PAUL
|
BOSTON MEDICAL CENTER
|
|
A Small Molecule to Activate Cetuximab to Kill K-RAS Mutant Colorectal Tumors
|
1R41CA174031-01
|
$266,641
|
$266,641
|
Jones, Barry
|
ARISAPH PHARMACEUTICALS, INC.
|
|
A Systems Genetics Analysis of Cancer Risk, Progression and Therapeutic Response
|
5U01CA084244-14
|
$759,738
|
$151,948
|
BALMAIN, ALLAN
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
A Tumor Suppressor Function for the c-Fes Tyrosine Kinase in Colon Cancer
|
5R01CA123756-05
|
$252,084
|
$252,084
|
SMITHGALL, THOMAS
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
AANCART: The National Center for Reducing Asian American Cancer Health Disparitie
|
3U54CA153499-03S1
|
$33,534
|
$8,384
|
CHEN, MOON
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
AANCART: The National Center for Reducing Asian American Cancer Health Disparitie
|
3U54CA153499-03S2
|
$50,001
|
$12,500
|
CHEN, MOON
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
AANCART: The National Center for Reducing Asian American Cancer Health Disparitie
|
3U54CA153499-03S3
|
$119,786
|
$29,947
|
CHEN, MOON
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
AANCART: The National Center for Reducing Asian American Cancer Health Disparitie
|
5U54CA153499-03
|
$968,834
|
$242,209
|
CHEN, MOON
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,258,475
|
$1,258,475
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-36
|
$7,725,062
|
$386,253
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
ACOSOG Community Clinical Oncology Program (CCOP) Research Base
|
5U10CA149950-02
|
$1,474,780
|
$368,695
|
Sloan, Jeff
|
MAYO CLINIC
|
|
ACOSOG Competing Renewal
|
7U10CA076001-16
|
$2,940,780
|
$882,234
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
ACTIVIN SIGNALING AND REGULATION IN THE COLON
|
5R01CA141057-03
|
$276,251
|
$276,251
|
JUNG, BARBARA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Adding Hispanics to Ongoing GWAS in Colorectal Cancer
|
5R01CA155101-02
|
$1,116,233
|
$1,116,233
|
Figueiredo, Jane
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
ZIABC010984
|
$1,556,987
|
$155,699
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Advanced glycation end products and colorectal cancer risk in women
|
5R03CA156626-02
|
$80,193
|
$80,193
|
JIAO, LI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Affinity Based Strategies to Fast Track Development of Colon Cancer Biomarkers
|
5U01CA152746-03
|
$610,846
|
$610,846
|
LAMPE, PAUL
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
African Americans and Colorectal Cancer: A Multilevel Model to Assess Factors for
|
5K01CA140358-04
|
$122,840
|
$122,840
|
GARZA, MARY
|
UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS
|
|
Alameda County Network Program for Reducing Cancer Disparities
|
3U54CA153506-03S1
|
$49,957
|
$3,497
|
BLOOM, JOAN
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
Alameda County Network Program for Reducing Cancer Disparities
|
3U54CA153506-03S2
|
$66,777
|
$4,674
|
BLOOM, JOAN
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
Alameda County Network Program for Reducing Cancer Disparities
|
3U54CA153506-03S3
|
$54,513
|
$3,816
|
BLOOM, JOAN
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
Alameda County Network Program for Reducing Cancer Disparities
|
5U54CA153506-03
|
$737,001
|
$51,590
|
BLOOM, JOAN
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
Alternative splicing in Ras transformed cells
|
ZIABC011397
|
$94,938
|
$37,975
|
Luo, Ji
|
CCR (NCI)
|
|
AmberGen"Phase I, Topic 309, Label-Free Multivariate Cancer Diagnosis"
|
N43CO120071-000
|
$199,767
|
$199,767
|
SEARS, CHRISTOPHER
|
AMBERGEN, INC
|
|
An in-silico method for epidemiological studies using Electronic Medical Records
|
5R01CA141307-04
|
$252,407
|
$126,204
|
Xu, Hua
|
VANDERBILT UNIVERSITY MED CTR
|
|
An Interactive E-Health Program to Promote Health Behaviors among Cancer Survivor
|
5R03CA142042-02
|
$92,236
|
$30,438
|
KREBS, PAUL
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Analyses of human T regulatory cells
|
ZIABC010973
|
$268,098
|
$26,810
|
Tsang, Kwong
|
CCR (NCI)
|
|
Analyses of Progression to Colon Cancer in a Spectrum of Pathways
|
5R01CA063677-18
|
$356,349
|
$356,349
|
DOVE, WILLIAM
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Animal model of Gardner's syndrome, a life threatening form of familial cancer
|
1R21CA156188-01A1
|
$168,653
|
$168,653
|
Bong, Yong-Sik
|
GEORGETOWN UNIVERSITY
|
|
AnnexinA2/progastrin and stem cells: dietary cancer prevention
|
3R01CA097959-09S1
|
$56,953
|
$56,953
|
SINGH, POMILA
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
|
AnnexinA2/progastrin and stem cells: dietary cancer prevention
|
5R01CA097959-09
|
$299,222
|
$299,222
|
SINGH, POMILA
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
|
Antibody Targeted Radiation and Immunotherapy for the Treatment of Solid Tumors
|
5P01CA043904-21
|
$1,218,233
|
$609,117
|
RAUBITSCHEK, ANDREW
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
|
ZIASC004020
|
$2,441,667
|
$366,250
|
Berzofsky, Jay
|
CCR (NCI)
|
|
Antioxidants and Antiinflammatory in Colorectal Cancer
|
5R01CA073674-14
|
$270,299
|
$270,299
|
KONG, AH-NG
|
RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK
|
|
Antitumor-Antibiotics from Marine Microorganisms
|
3R37CA044848-26S1
|
$77,500
|
$11,625
|
FENICAL, WILLIAM
|
UNIVERSITY OF CALIFORNIA AT SAN DIEGO
|
|
Antitumor-Antibiotics from Marine Microorganisms
|
5R37CA044848-26
|
$373,010
|
$55,952
|
FENICAL, WILLIAM
|
UNIVERSITY OF CALIFORNIA AT SAN DIEGO
|
|
APC and Retinoids in Zebrafish Enterocyte Development
|
5R01CA116468-08
|
$283,209
|
$283,209
|
JONES, DAVID
|
UNIVERSITY OF UTAH
|
|
APC Tumor Suppressor in Cell Differentiation and Death
|
5R01CA105038-07
|
$262,280
|
$262,280
|
Ahmed, Yasmath
|
DARTMOUTH COLLEGE
|
Total relevant funding to Colon/Rectum for this search: $256,254,674
|